Pathophysiologie und Therapie der diabetischen Retinopathie

• LITERATUR

• 1 Ashton N. Injection of retinal vascular system in diabetic retinopathy. Brit. J. Ophthal 1950; 34: 38
• 2 Ashton N. Diabetic retinopathy. Proc. Roy. Soc. Med 1951; 44: 747
• 3 Baumann R. H, Cottier P. Natriumfluoreszein zur Bestimmung des Herzminutenvolumens mit Hilfe der Dilutionsmethode nach Hailton-Stewart. Helv. med. Acta 1960; 27: 18
• 4 Blankenship G. Pars plana vitrectomy for diabetic retinopathy: A report of eight years experiences. Mod. Probl. Ophthalmol 1979; 20: 376
• 5 Burditt A. F, Caird F. I, Draper G. J. The natural history of diabetic retinopathy. Q. J. M 1968; 37: 303
• 6 Caird F. I. Epidemiology of Diabetic Retinopathy. In Lynn J. R, Snyder W. B, Vaiser A. (Ed.) Diabetic Retinopathy Grune & Stratton; New York: 1974
• 7 Committee on Blindness: Report on Diabetic Blindness in the United Kingdom. London: British Diabetic Association; 1970
• 8 Davis M. D. Definition, Classification and Course of Diabetic Retinopathy. In Lynn J. R, Snyder W. B, Vaiser A. (Ed.) Diabetic Retinopathy Grune & Stratton; New York: 1974
• 9 Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Amer. J. Ophthalmol 1976; 81: 383
• 10 Dobree J. H. Spontaneous and induced changes in proliferative diabetic retinopathy. Transactions of the Ophthalmological Societies of U. K. Vol.LXXXIV. J. & A. Churchill Ltd; London: 1964
• 11 Duke-Elder S, Dobree J. H. Diseases of the retina. System of Ophthalmology. Vol. X. Henry Kimpton; London: 1967
• 12 Dupuy E, Guillausseau P. J, Gaudeul P, Kartalis G, Wild A. M, Pastureau A, Soria C, Malbec D, Duprey J, Lubetzki J, Cean J. P. Fonctions plaquettaires des diabetiques ayant une angiopathie. La Nouvelle Presse Medicale 1979; 39: 3123
• 13 Folkman J, Merler E, Abermathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med 1971; 133: 275
• 14 Freyler H, Kiemen U. Topographische Aspekte der Progredienz der diabetischen Retinopathie. Versuchsanordnung zur Beurteilung medikamentöser Beeinflußbarkeit. Klin. Mbl. Augenheilk 1981; 178: 350
• 15 Freyler H, Kiemen U, Prskavec F. H, Scheimbauer I. Ein neues Klassifikationsschema der nichtproliferativen diabetischen Retinopathie. Graefes Arch. klin. exper. Ophthalmologie 1981; 217: 69
• 16 Henkind P. Microcirculation of the peripapillary retina. Trans. Amer. Acad. Ophthal. Otolaryngol 1969; 73: 890
• 17 Hodge J. V, Dollery C. T. Retinal soft exudates. A clinical study by colour and fluorescence photography. Quart. J. Med 1964; 33: 117
• 18 Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 1981; 30: 601
• 19 Klöti R. Vitrektomie. I. Ein neues Instrument für die hintere Vitrektomie. Albrecht v. Graefes Arch. klin. Ophthalmol 1973; 187: 161
• 20 Kohner E. M. Dynamic changes in the microcirculation of diabetics as related to diabetic microangiopathy. In Ditzel J, Poulsen J. E. (Ed.) Diabetic Microangiopathy. Suppl. 578 Acta Med. Scand 1975
• 21 Lawson P, White M, Rosenstock J, Kohner E. Failure of continuous subcutaneous insulin infusions as a therapeutic tool in severe forms of diabetic retinopathy. Diabe-tologia 27/ 1981; 5: 510
• 22 Lawson P, Champion C. M, Canny C, Kingsley R, White M. C, Dupré J, Kohner E. M. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Brit. J. Ophthalmol 1982; 66: 762
• 23 Lundbaek K. Late developments in long-term diabetic vascular diseases. In Oberdisse K, Jahnke K. (Ed.) Diabetes mellitus. III. Kongress International Diabetes Federation Stuttgart; West Germany: p. 141 Georg Thieme Verl. KG 1958
• 24 Machemer R, Büttner H, Norton E. W. D. Vitrectomy, a pars plana approach. Trans. Amer. Acad. Ophthal. Otolaryngol 1971; 75: 813
• 25 Mandelcorn M. S, Blankenship G, Machemer R. Pars plana vitrectomy for the management of severe diabetic retinopathy. Amer. J. Ophthalmol 1976; 81: 561
• 26 Meyer-Schwickerath G. Lichtkoagulation. Bücherei des Augenarztes. Heft. 1959: 33
• 27 Michels R. G. Vitreous surgery in proliferative diabetic retinopathy. In Shimizu K, Oosterhuis J. A. (Ed.) Acta XXIII Consilium Ophthalmologicum, Kyoto, 1978 Pt I Amsterdam Excerpta Medica; 1979: 420
• 28 Novotny H. R, Alvis D. L. A method of photographing fluorescence in circulating blood of the human eye. USAF Sch. Aviat. Med. 60###82 (1960) 1.4; Ref. Amer. J. Ophthal 1960; 50: 176
• 29 Riaskoff S. Die diabetische Retinopathie und ihre Behandlung mit Lichtkoagulation. Ed Junk W, Gravenhage S. 1972
• 30 Soler N. G, Fitzgerald M. G, Malins J, Summers R. O. C. Retinopathy at diagnosis of diabetes, with special reference to patients under 40 years of age. Brit. Med. J 1969; 3: 567
• 31 Tamborlane W. V, Puklin J. E, Bergman M, Verdonk C, Rudolf M. C, Felig Ph, Genel M, Sherwin R. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care, 1982; 5: 1
• 32 Townsend C, Bailey J, Kohner E. Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study. Brit. J. Ophthal 1980; 64: 382
• 33 Vedel-Jensen N. The cause of blindness in 1000 consecutive new members of the Danish Society for Blind. Dan. Med. Bull 1962; 9: 185
• 34 Vink R. Fluorescein angiography in diabetic retinopathy. Diss. Leiden. 1969
• 35 Waldhäusl W, Freyler H, Bratusch-Marrain P, Vierhapper H, Bruneder H. Kontinuierliche subkutane Insulininfusion (CSII): Langzeitbehandlung bei einer selektierten Gruppe insulinabhängiger Diabetiker. Dtsch. med. Wschr 1983; 108: 570
• 36 Wessing A. Fluoreszenzangiographie der Retina. Lehrbuch und Atlas. Georg Thieme Verlag; Stuttgart: 1968
• 37 White P. Natural course and prognosis of juvenile diabetes. Diabetes 1956; 5: 445
• 38 White P. Childhood diabetes. Diabetes 1960; 9: 345
• 39 Wise G. N, Dollery C. T, Henkind P. The retinal circulation. Harper & Row, Publ. New York: 1971